Details for Patent: 8,772,338
Summary for Patent: 8,772,338
| Title: | Enhanced bimatoprost ophthalmic solution |
| Abstract: | A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. |
| Inventor(s): | Chin-Ming Chang, James N. Chang, Rhett M. Schiffman, R. Scott Jordan, Joan-En Chang-Lin |
| Assignee: | Allergan Inc |
| Application Number: | US13/827,774 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,772,338 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,772,338
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,772,338
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 055050 | ⤷ Start Trial | |||
| Austria | E431152 | ⤷ Start Trial | |||
| Australia | 2006227757 | ⤷ Start Trial | |||
| Brazil | PI0607447 | ⤷ Start Trial | |||
| Canada | 2585691 | ⤷ Start Trial | |||
| China | 101137383 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
